A Co-Design Approach To Support Oral Anticancer Medication Use In Breast Cancer.
E
Ephrem Abebe, MD
Primary Investigator
Overview
1. To identify unmet medication management needs
of patients with breast cancer receiving oral anticancer medications.
2.
To co-design
early prototype intervention with patients to support medication management needs
of breast cancer.
Description
This is a single-site
study to assess patients’ experience related to oral anticancer medication use and
identify unmet need of patients. We plan to enroll 15-20 patients for a journey
mapping interview and additional 5-7 patients for focus group meeting same
eligibility criteria. Topics to explore include: medication management tasks,
tools used to support such tasks, information received, persons involved and
support received, communication patient had and the contexts where medication
use occurs (i.e., organizational, spatial, and socio-cultural contexts).
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
breast cancer, cancer treatment
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria:
≥ 18 years old and diagnosed with Breast cancer.
Currently receiving orally administered anticancer
medications such as targeted agents and hormonal agents (examples listed in
table 1) or recent history of using any of these drugs (last dose within 3-6
months) at the time of recruitment
Exclusion Criteria:
- · Severe illness that precludes voluntary consent· Hearing, vision, and cognitive impairment· Unable to provide verbal consent without assistance
Updated on
27 Apr 2024.
Study ID: 18075; PHARM-IUSCCC-0821
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
